Ethambutol dihydrochloride is a bacteriostatic antimycobacterial agent primarily prescribed as part of combination therapy to treat tuberculosis and infections caused by Mycobacterium avium complex and… Read more
Ethambutol dihydrochloride is a bacteriostatic antimycobacterial agent primarily prescribed as part of combination therapy to treat tuberculosis and infections caused by Mycobacterium avium complex and Mycobacterium kansasii. Pharmaceutical laboratories utilize high-quality reference standards of this drug, alongside its related pharmacopeial and non-pharmacopeial impurities, to perform rigorous impurity profiling and method validation. These analytical standards are essential for verifying the purity, identity, and concentration of the active pharmaceutical ingredient during stability testing and routine quality control processes. Furthermore, stable isotope labelled compounds are available to serve as internal standards, facilitating accurate quantification in complex matrices for pharmacokinetic studies and bioanalytical method development. By incorporating these materials into analytical workflows, researchers ensure compliance with regulatory guidelines and maintain the structural integrity of ethambutol-based formulations throughout their development and production lifecycle.